canceldeath
Sign in
Rapamycin
Registry update — unassessed

The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals: A Retrospective Study and Review With Clinical Implications

Trial registry update: COMPLETED. No results reported in the supplied registry record.

OBSERVATIONALMinor significance
Share on X
Reporter brief

What this changes

The finding has not established an approved change to our evidence assessment.

Source date: Aug 13, 2024 · Discovered: Sep 19, 2026 · Assessed: — · Historical research backfill

What it does not prove

  • Retrospective design cannot establish causation or confirm that formulation differences caused observed blood level variations, as confounding factors were not controlled. The study does not report whether different blood levels translated to differences in clinical outcomes or longevity effects. Sample size and effect sizes were not reported, limiting assessment of statistical reliability or clinical significance of any differences found.

Extracted from supplied source material; model confidence is not a measured probability of correctness.

Study details

Design
Observational
Sample size
—
Duration
—
Population
normative aging individuals
Primary outcome
relative bioavailability ratio between compounded rapamycin and generic rapamycin; blood rapamycin levels
Effect size
—
Significance
Not reported
Journal
AgelessRx
Published
Aug 13, 2024

Sources

Primary source

Recorded source passages

Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.

This study collected real-world evidence to better understand and define the relative bioavailability ratio between compounded rapamycin and generic rapamycin, with a specific focus on relative efficacy in increasing rapamycin levels in the blood (blood rapamycin levels).

Source versions

Version 1: Unassessed

Version 1: Superseded

Assessment history

Discussion (0)

One thread per scientific event, no matter how many outlets covered it.

Sign in to join the discussion.

No comments yet

Be the first to weigh in on this evidence.